Rank | Gene Set | Z-score |
---|---|---|
1 | response to pheromone (GO:0019236) | 6.03817773 |
2 | response to peptidoglycan (GO:0032494) | 4.32805902 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.26159207 |
4 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.24027537 |
5 | immunoglobulin mediated immune response (GO:0016064) | 4.03127144 |
6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.02997382 |
7 | B cell receptor signaling pathway (GO:0050853) | 3.92936530 |
8 | negative regulation of interleukin-12 production (GO:0032695) | 3.90253278 |
9 | regulation of antigen processing and presentation (GO:0002577) | 3.86439036 |
10 | positive regulation of antigen processing and presentation (GO:0002579) | 3.85728969 |
11 | germinal center formation (GO:0002467) | 3.82878289 |
12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.74746748 |
13 | cellular response to exogenous dsRNA (GO:0071360) | 3.67045002 |
14 | cellular response to ATP (GO:0071318) | 3.64977016 |
15 | macrophage activation involved in immune response (GO:0002281) | 3.62902056 |
16 | defense response to protozoan (GO:0042832) | 3.62541733 |
17 | response to muramyl dipeptide (GO:0032495) | 3.59645185 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58957563 |
19 | response to protozoan (GO:0001562) | 3.58669166 |
20 | NIK/NF-kappaB signaling (GO:0038061) | 3.58417515 |
21 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.56838418 |
22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.53606634 |
23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.53606634 |
24 | modulation by symbiont of host immune response (GO:0052553) | 3.53606634 |
25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.53606634 |
26 | modulation by symbiont of host defense response (GO:0052031) | 3.53606634 |
27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.53606634 |
28 | regulation of interferon-alpha production (GO:0032647) | 3.51541478 |
29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.49216487 |
30 | T-helper 1 type immune response (GO:0042088) | 3.46925093 |
31 | positive regulation of interferon-alpha production (GO:0032727) | 3.45365853 |
32 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.43165343 |
33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.40322911 |
34 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33011019 |
35 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.28876028 |
36 | positive regulation of defense response to virus by host (GO:0002230) | 3.25005149 |
37 | mannose metabolic process (GO:0006013) | 3.24359681 |
38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22383822 |
39 | interferon-gamma production (GO:0032609) | 3.15179723 |
40 | positive thymic T cell selection (GO:0045059) | 3.14148168 |
41 | tolerance induction (GO:0002507) | 3.13070329 |
42 | positive regulation of mast cell activation (GO:0033005) | 3.12745490 |
43 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.11322484 |
44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05022323 |
45 | regulation of mast cell activation (GO:0033003) | 3.01188753 |
46 | regulation of interleukin-12 production (GO:0032655) | 3.00252907 |
47 | B cell homeostasis (GO:0001782) | 2.99939912 |
48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.97908962 |
49 | purinergic receptor signaling pathway (GO:0035587) | 2.94272651 |
50 | B cell mediated immunity (GO:0019724) | 2.93058572 |
51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.92457482 |
52 | negative regulation of cell killing (GO:0031342) | 2.92457482 |
53 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.92301630 |
54 | positive regulation of protein homooligomerization (GO:0032464) | 2.90328124 |
55 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.90292257 |
56 | response to type I interferon (GO:0034340) | 2.85560496 |
57 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85500812 |
58 | myeloid dendritic cell differentiation (GO:0043011) | 2.85391663 |
59 | positive regulation of interleukin-12 production (GO:0032735) | 2.83282570 |
60 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79197672 |
61 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.78908507 |
62 | detection of bacterium (GO:0016045) | 2.78273152 |
63 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.77510609 |
64 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.77253476 |
65 | regulation of interferon-beta production (GO:0032648) | 2.76268501 |
66 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.76248270 |
67 | myeloid dendritic cell activation (GO:0001773) | 2.75611247 |
68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.75135192 |
69 | positive regulation of mast cell degranulation (GO:0043306) | 2.75135192 |
70 | positive regulation of heat generation (GO:0031652) | 2.73303393 |
71 | regulation of defense response to virus by host (GO:0050691) | 2.71803750 |
72 | regulation of T-helper cell differentiation (GO:0045622) | 2.71622992 |
73 | cellular response to type I interferon (GO:0071357) | 2.71128763 |
74 | type I interferon signaling pathway (GO:0060337) | 2.71128763 |
75 | myeloid cell activation involved in immune response (GO:0002275) | 2.70848538 |
76 | positive regulation of B cell proliferation (GO:0030890) | 2.70330240 |
77 | T cell lineage commitment (GO:0002360) | 2.70180155 |
78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.69906955 |
79 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.69768858 |
80 | positive regulation of interferon-beta production (GO:0032728) | 2.69102708 |
81 | cellular response to interferon-gamma (GO:0071346) | 2.68827261 |
82 | negative thymic T cell selection (GO:0045060) | 2.68248670 |
83 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.68045704 |
84 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.68040621 |
85 | negative regulation of interleukin-6 production (GO:0032715) | 2.67601183 |
86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67228996 |
87 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.66852822 |
88 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.66705300 |
89 | behavioral response to nicotine (GO:0035095) | 2.66554089 |
90 | detection of other organism (GO:0098543) | 2.64924694 |
91 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63432967 |
92 | tryptophan catabolic process (GO:0006569) | 2.62826680 |
93 | indole-containing compound catabolic process (GO:0042436) | 2.62826680 |
94 | indolalkylamine catabolic process (GO:0046218) | 2.62826680 |
95 | response to exogenous dsRNA (GO:0043330) | 2.59065481 |
96 | thymic T cell selection (GO:0045061) | 2.58695600 |
97 | regulation of histone phosphorylation (GO:0033127) | 2.58400091 |
98 | regulation of germinal center formation (GO:0002634) | 2.57630699 |
99 | negative regulation of T cell mediated immunity (GO:0002710) | 2.56863758 |
100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.56256884 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.31669649 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.56807639 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.47951059 |
4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.99902053 |
5 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.96141956 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 2.91244374 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72023681 |
8 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.63882413 |
9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.51016405 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.49074968 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.45943615 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42188081 |
13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38990721 |
14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.36036413 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28323026 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12774602 |
17 | MAF_26560356_Chip-Seq_TH1_Human | 2.03334428 |
18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00618981 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00155644 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.97878912 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96644078 |
22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88342654 |
23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87450604 |
24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85411360 |
25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.84990628 |
26 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.82067668 |
27 | MAF_26560356_Chip-Seq_TH2_Human | 1.79073775 |
28 | * MYB_26560356_Chip-Seq_TH2_Human | 1.69202862 |
29 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.66599665 |
30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66329668 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65840343 |
32 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64510815 |
33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56302819 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56196282 |
35 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.55836779 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55770039 |
37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54831588 |
38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51094926 |
39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49778774 |
40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43724284 |
41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43401652 |
42 | P68_20966046_ChIP-Seq_HELA_Human | 1.42464351 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42297332 |
44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41293894 |
45 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40065608 |
46 | * MYB_26560356_Chip-Seq_TH1_Human | 1.39847322 |
47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35268771 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34179686 |
49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34081916 |
50 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.34058666 |
51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33343481 |
52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31367543 |
53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28601031 |
54 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.28443368 |
55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28073720 |
56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27591951 |
57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27163833 |
58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26591524 |
59 | P300_27268052_Chip-Seq_Bcells_Human | 1.25473010 |
60 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24670194 |
61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24390360 |
62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24173577 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21870663 |
64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21751950 |
65 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21424836 |
66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19483949 |
67 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18946200 |
68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18111526 |
69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17180494 |
70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17042959 |
71 | ERA_21632823_ChIP-Seq_H3396_Human | 1.16304050 |
72 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16076326 |
73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14835409 |
74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13256602 |
75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12479772 |
76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12252809 |
77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10882551 |
78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10613960 |
79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09590212 |
80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08171256 |
81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08084104 |
82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07125976 |
83 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06783753 |
84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05763755 |
85 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05646691 |
86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04033842 |
87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03695495 |
88 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.03630065 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02804331 |
90 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02042208 |
91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01193593 |
92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00777738 |
93 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00454091 |
94 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00095850 |
95 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99006465 |
96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97602966 |
97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97419028 |
98 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.97347286 |
99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96732774 |
100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96072369 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000685_abnormal_immune_system | 3.63703024 |
2 | MP0005671_abnormal_response_to | 3.52630010 |
3 | MP0005387_immune_system_phenotype | 3.47055106 |
4 | MP0001790_abnormal_immune_system | 3.47055106 |
5 | MP0001835_abnormal_antigen_presentation | 3.45632703 |
6 | MP0002138_abnormal_hepatobiliary_system | 3.22346182 |
7 | MP0001800_abnormal_humoral_immune | 3.17485796 |
8 | MP0003303_peritoneal_inflammation | 3.09281963 |
9 | MP0003436_decreased_susceptibility_to | 3.02234512 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.92082384 |
11 | MP0005000_abnormal_immune_tolerance | 2.81174558 |
12 | MP0002452_abnormal_antigen_presenting | 2.63858024 |
13 | MP0002723_abnormal_immune_serum | 2.61396796 |
14 | MP0009785_altered_susceptibility_to | 2.35201998 |
15 | MP0002419_abnormal_innate_immunity | 2.34234651 |
16 | MP0005025_abnormal_response_to | 2.31444778 |
17 | MP0002420_abnormal_adaptive_immunity | 2.30153164 |
18 | MP0001819_abnormal_immune_cell | 2.27567179 |
19 | MP0001986_abnormal_taste_sensitivity | 2.25282156 |
20 | MP0003724_increased_susceptibility_to | 2.23682519 |
21 | MP0001873_stomach_inflammation | 2.18434105 |
22 | MP0005167_abnormal_blood-brain_barrier | 2.12495159 |
23 | MP0005310_abnormal_salivary_gland | 2.01707832 |
24 | MP0002254_reproductive_system_inflammat | 1.98539483 |
25 | MP0009840_abnormal_foam_cell | 1.91480819 |
26 | MP0003172_abnormal_lysosome_physiology | 1.84712886 |
27 | MP0000716_abnormal_immune_system | 1.81199802 |
28 | MP0006082_CNS_inflammation | 1.78284340 |
29 | MP0009764_decreased_sensitivity_to | 1.77824553 |
30 | MP0009333_abnormal_splenocyte_physiolog | 1.67591190 |
31 | MP0002405_respiratory_system_inflammati | 1.65459939 |
32 | MP0005058_abnormal_lysosome_morphology | 1.64700604 |
33 | MP0003763_abnormal_thymus_physiology | 1.64149083 |
34 | MP0002398_abnormal_bone_marrow | 1.62914649 |
35 | MP0001845_abnormal_inflammatory_respons | 1.62232598 |
36 | MP0003195_calcinosis | 1.61414864 |
37 | MP0010155_abnormal_intestine_physiology | 1.57876173 |
38 | MP0009278_abnormal_bone_marrow | 1.57516554 |
39 | MP0001533_abnormal_skeleton_physiology | 1.49486476 |
40 | MP0004510_myositis | 1.48836709 |
41 | MP0004947_skin_inflammation | 1.48341187 |
42 | MP0000689_abnormal_spleen_morphology | 1.44874364 |
43 | MP0004381_abnormal_hair_follicle | 1.38515825 |
44 | MP0002429_abnormal_blood_cell | 1.38124567 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.35787764 |
46 | MP0003300_gastrointestinal_ulcer | 1.35011196 |
47 | MP0008469_abnormal_protein_level | 1.34862572 |
48 | MP0005174_abnormal_tail_pigmentation | 1.26136775 |
49 | MP0002722_abnormal_immune_system | 1.16366399 |
50 | MP0004043_abnormal_pH_regulation | 1.15169324 |
51 | MP0002933_joint_inflammation | 1.08811203 |
52 | MP0001663_abnormal_digestive_system | 1.08103813 |
53 | MP0003806_abnormal_nucleotide_metabolis | 1.07099624 |
54 | MP0001968_abnormal_touch/_nociception | 1.04775599 |
55 | MP0008872_abnormal_physiological_respon | 1.00968743 |
56 | MP0002277_abnormal_respiratory_mucosa | 0.96506322 |
57 | MP0003646_muscle_fatigue | 0.96163974 |
58 | MP0002998_abnormal_bone_remodeling | 0.95745026 |
59 | MP0001853_heart_inflammation | 0.95269331 |
60 | MP0003075_altered_response_to | 0.93130083 |
61 | MP0000604_amyloidosis | 0.93085907 |
62 | MP0005423_abnormal_somatic_nervous | 0.91541381 |
63 | MP0003183_abnormal_peptide_metabolism | 0.90434799 |
64 | MP0002653_abnormal_ependyma_morphology | 0.90420905 |
65 | MP0003136_yellow_coat_color | 0.89690605 |
66 | MP0004742_abnormal_vestibular_system | 0.89434561 |
67 | MP0001501_abnormal_sleep_pattern | 0.88441732 |
68 | MP0002693_abnormal_pancreas_physiology | 0.88273762 |
69 | MP0003045_fibrosis | 0.84589394 |
70 | MP0003690_abnormal_glial_cell | 0.83329986 |
71 | MP0000015_abnormal_ear_pigmentation | 0.80018700 |
72 | MP0000703_abnormal_thymus_morphology | 0.79721090 |
73 | MP0001545_abnormal_hematopoietic_system | 0.79487151 |
74 | MP0005397_hematopoietic_system_phenotyp | 0.79487151 |
75 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78563288 |
76 | MP0000383_abnormal_hair_follicle | 0.75830267 |
77 | MP0005464_abnormal_platelet_physiology | 0.74326851 |
78 | MP0002064_seizures | 0.72530898 |
79 | MP0005166_decreased_susceptibility_to | 0.71769061 |
80 | MP0000371_diluted_coat_color | 0.71150153 |
81 | MP0009745_abnormal_behavioral_response | 0.70241901 |
82 | MP0008874_decreased_physiological_sensi | 0.70070888 |
83 | MP0003866_abnormal_defecation | 0.69956101 |
84 | MP0002136_abnormal_kidney_physiology | 0.68429148 |
85 | MP0002166_altered_tumor_susceptibility | 0.67103272 |
86 | MP0000249_abnormal_blood_vessel | 0.66230759 |
87 | MP0009046_muscle_twitch | 0.65812106 |
88 | MP0002006_tumorigenesis | 0.65274013 |
89 | MP0005645_abnormal_hypothalamus_physiol | 0.64759238 |
90 | MP0005076_abnormal_cell_differentiation | 0.60921291 |
91 | MP0005381_digestive/alimentary_phenotyp | 0.60092910 |
92 | MP0000470_abnormal_stomach_morphology | 0.60063936 |
93 | MP0000343_altered_response_to | 0.59289366 |
94 | MP0005448_abnormal_energy_balance | 0.58761401 |
95 | MP0000920_abnormal_myelination | 0.58452336 |
96 | MP0005075_abnormal_melanosome_morpholog | 0.57478797 |
97 | MP0001765_abnormal_ion_homeostasis | 0.55944034 |
98 | MP0005551_abnormal_eye_electrophysiolog | 0.55325059 |
99 | MP0003453_abnormal_keratinocyte_physiol | 0.54908702 |
100 | MP0008961_abnormal_basal_metabolism | 0.54595975 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.51738401 |
2 | Increased cerebral lipofuscin (HP:0011813) | 4.44302302 |
3 | Panhypogammaglobulinemia (HP:0003139) | 4.31254550 |
4 | Gastrointestinal stroma tumor (HP:0100723) | 4.16995614 |
5 | Agammaglobulinemia (HP:0004432) | 4.09583763 |
6 | Recurrent cutaneous fungal infections (HP:0011370) | 4.05960260 |
7 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.05960260 |
8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.88141312 |
9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.87441763 |
10 | Recurrent fungal infections (HP:0002841) | 3.69994199 |
11 | Congenital stationary night blindness (HP:0007642) | 3.52569842 |
12 | Vacuolated lymphocytes (HP:0001922) | 3.40585606 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.28542575 |
14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.28542575 |
15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.28542575 |
16 | Meningitis (HP:0001287) | 3.26939870 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.26810962 |
18 | Stomatitis (HP:0010280) | 3.26471268 |
19 | Recurrent viral infections (HP:0004429) | 3.19649683 |
20 | Colitis (HP:0002583) | 3.12711918 |
21 | Encephalitis (HP:0002383) | 3.08221431 |
22 | Optic neuritis (HP:0100653) | 2.92759903 |
23 | Retrobulbar optic neuritis (HP:0100654) | 2.92759903 |
24 | Vasculitis (HP:0002633) | 2.89602195 |
25 | Recurrent bacterial skin infections (HP:0005406) | 2.87814798 |
26 | Abnormality of macrophages (HP:0004311) | 2.86953682 |
27 | Recurrent skin infections (HP:0001581) | 2.80335102 |
28 | Pustule (HP:0200039) | 2.80041686 |
29 | Attenuation of retinal blood vessels (HP:0007843) | 2.78023730 |
30 | Recurrent abscess formation (HP:0002722) | 2.72266584 |
31 | Recurrent sinusitis (HP:0011108) | 2.71524697 |
32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70672069 |
33 | Myositis (HP:0100614) | 2.66186015 |
34 | Global brain atrophy (HP:0002283) | 2.65330223 |
35 | Autoimmune thrombocytopenia (HP:0001973) | 2.64031867 |
36 | Orchitis (HP:0100796) | 2.63972529 |
37 | Mesangial abnormality (HP:0001966) | 2.62645176 |
38 | Clumsiness (HP:0002312) | 2.57509705 |
39 | Abnormality of T cell physiology (HP:0011840) | 2.55138101 |
40 | Abnormality of B cell number (HP:0010975) | 2.55104486 |
41 | IgG deficiency (HP:0004315) | 2.51948784 |
42 | Pulmonary infiltrates (HP:0002113) | 2.45825334 |
43 | Inflammation of the large intestine (HP:0002037) | 2.32055248 |
44 | B lymphocytopenia (HP:0010976) | 2.30054883 |
45 | Genetic anticipation (HP:0003743) | 2.28253706 |
46 | Dysostosis multiplex (HP:0000943) | 2.25048340 |
47 | Hemoptysis (HP:0002105) | 2.24315040 |
48 | Eczematoid dermatitis (HP:0000976) | 2.23229125 |
49 | Restrictive lung disease (HP:0002091) | 2.22442127 |
50 | Verrucae (HP:0200043) | 2.18617875 |
51 | Papilloma (HP:0012740) | 2.18617875 |
52 | Decreased circulating renin level (HP:0003351) | 2.18135938 |
53 | Recurrent bronchitis (HP:0002837) | 2.16756876 |
54 | Abnormality of T cells (HP:0002843) | 2.15960794 |
55 | Gastrointestinal inflammation (HP:0004386) | 2.15276092 |
56 | Lymphopenia (HP:0001888) | 2.14914039 |
57 | Mutism (HP:0002300) | 2.13402000 |
58 | Chronic otitis media (HP:0000389) | 2.12428502 |
59 | Stomach cancer (HP:0012126) | 2.05337221 |
60 | Increased serum ferritin (HP:0003281) | 2.04308211 |
61 | Pendular nystagmus (HP:0012043) | 2.01564502 |
62 | Bone cyst (HP:0012062) | 2.00004788 |
63 | Gastrointestinal infarctions (HP:0005244) | 1.98418221 |
64 | Polydipsia (HP:0001959) | 1.96087864 |
65 | Abnormal drinking behavior (HP:0030082) | 1.96087864 |
66 | Flat occiput (HP:0005469) | 1.95209793 |
67 | Emphysema (HP:0002097) | 1.95004438 |
68 | Increased IgE level (HP:0003212) | 1.94181662 |
69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94021024 |
70 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94021024 |
71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94021024 |
72 | Keratoconjunctivitis (HP:0001096) | 1.93267410 |
73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92967165 |
74 | Birth length less than 3rd percentile (HP:0003561) | 1.92380657 |
75 | Progressive inability to walk (HP:0002505) | 1.91048992 |
76 | Hematochezia (HP:0002573) | 1.89570313 |
77 | IgA deficiency (HP:0002720) | 1.86646609 |
78 | Viral hepatitis (HP:0006562) | 1.86307679 |
79 | Tinnitus (HP:0000360) | 1.86250276 |
80 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84802695 |
81 | Loss of speech (HP:0002371) | 1.82620495 |
82 | Large for gestational age (HP:0001520) | 1.82408637 |
83 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80220850 |
84 | Progressive cerebellar ataxia (HP:0002073) | 1.79960048 |
85 | Abnormality of binocular vision (HP:0011514) | 1.79170729 |
86 | Diplopia (HP:0000651) | 1.79170729 |
87 | Protruding tongue (HP:0010808) | 1.77749635 |
88 | Recurrent pneumonia (HP:0006532) | 1.77408989 |
89 | Keratoconjunctivitis sicca (HP:0001097) | 1.76364906 |
90 | Leukopenia (HP:0001882) | 1.73517475 |
91 | Parakeratosis (HP:0001036) | 1.73397996 |
92 | Abnormality of the pleura (HP:0002103) | 1.73067383 |
93 | Urticaria (HP:0001025) | 1.73012579 |
94 | Amelogenesis imperfecta (HP:0000705) | 1.72455898 |
95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71862117 |
96 | Abnormality of the prostate (HP:0008775) | 1.71491105 |
97 | Polyneuropathy (HP:0001271) | 1.70512529 |
98 | Inability to walk (HP:0002540) | 1.67815641 |
99 | Cheilitis (HP:0100825) | 1.67426528 |
100 | Abolished electroretinogram (ERG) (HP:0000550) | 1.66628217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.97502203 |
2 | ACVR1B | 3.55355574 |
3 | BMPR1B | 3.46517405 |
4 | RIPK4 | 3.40181610 |
5 | BLK | 2.77908927 |
6 | ADRBK2 | 2.54952646 |
7 | TGFBR1 | 2.43899506 |
8 | MAP3K14 | 2.42366108 |
9 | SIK2 | 2.36930506 |
10 | IKBKB | 2.35897368 |
11 | IRAK4 | 2.09672728 |
12 | KIT | 2.07565547 |
13 | IRAK3 | 2.06091304 |
14 | FRK | 1.99017752 |
15 | TXK | 1.91609307 |
16 | IKBKE | 1.91281898 |
17 | TBK1 | 1.88848005 |
18 | SYK | 1.75468559 |
19 | DAPK2 | 1.70765926 |
20 | CSF1R | 1.70635320 |
21 | CHUK | 1.64839084 |
22 | TAOK3 | 1.64220313 |
23 | PRPF4B | 1.58502469 |
24 | MATK | 1.57545880 |
25 | TYK2 | 1.52871287 |
26 | MAPK15 | 1.46797002 |
27 | SIK3 | 1.42542301 |
28 | CDC42BPA | 1.40337944 |
29 | CAMK1D | 1.34156788 |
30 | ERN1 | 1.32195555 |
31 | GRK6 | 1.30112290 |
32 | MAP3K13 | 1.28916120 |
33 | LYN | 1.21008361 |
34 | MAPKAPK3 | 1.20408397 |
35 | CSK | 1.16923798 |
36 | BTK | 1.12318498 |
37 | NME2 | 1.11935798 |
38 | WNK4 | 1.11449472 |
39 | IRAK1 | 1.10108072 |
40 | TNK2 | 1.09074865 |
41 | TLK1 | 1.08745816 |
42 | GRK1 | 1.08124451 |
43 | FGR | 1.07598156 |
44 | MAP3K11 | 1.06413631 |
45 | JAK3 | 1.04240334 |
46 | ZAP70 | 0.95043294 |
47 | SMG1 | 0.94950203 |
48 | CAMKK2 | 0.92983751 |
49 | MAPK12 | 0.92886967 |
50 | CAMKK1 | 0.91672606 |
51 | RPS6KA6 | 0.88577113 |
52 | MAP2K6 | 0.88563119 |
53 | TRIB3 | 0.88358178 |
54 | BMPR2 | 0.88047881 |
55 | EEF2K | 0.86815984 |
56 | MAP2K2 | 0.83654625 |
57 | FES | 0.81677787 |
58 | LCK | 0.80884487 |
59 | PRKCQ | 0.79536834 |
60 | ITK | 0.73563261 |
61 | JAK1 | 0.73264877 |
62 | TRPM7 | 0.72027497 |
63 | MAPK7 | 0.71272048 |
64 | IRAK2 | 0.68470892 |
65 | HIPK2 | 0.67141821 |
66 | HCK | 0.66136151 |
67 | MARK3 | 0.64984261 |
68 | SIK1 | 0.64412926 |
69 | PDK1 | 0.63692933 |
70 | PRKD2 | 0.62741356 |
71 | MAPK11 | 0.61540077 |
72 | MAP3K1 | 0.59166409 |
73 | PIM1 | 0.56216747 |
74 | PRKCH | 0.55614627 |
75 | ZAK | 0.54992338 |
76 | MAP2K3 | 0.54839468 |
77 | MELK | 0.54041687 |
78 | PDPK1 | 0.54002278 |
79 | GRK7 | 0.52671583 |
80 | TAOK1 | 0.52159092 |
81 | BCKDK | 0.51905069 |
82 | CDK4 | 0.49810299 |
83 | ADRBK1 | 0.49797663 |
84 | TEC | 0.46475474 |
85 | MAPK4 | 0.42981867 |
86 | JAK2 | 0.40492069 |
87 | CDK8 | 0.38852441 |
88 | MAP2K1 | 0.38566199 |
89 | TYRO3 | 0.38421904 |
90 | MAPKAPK5 | 0.36365515 |
91 | RPS6KL1 | 0.36092315 |
92 | RPS6KC1 | 0.36092315 |
93 | STK11 | 0.35935372 |
94 | CAMK1G | 0.35650564 |
95 | MAPK13 | 0.35229941 |
96 | WNK1 | 0.35211581 |
97 | MARK2 | 0.34309021 |
98 | DDR2 | 0.32545370 |
99 | ABL1 | 0.31847139 |
100 | MAPK3 | 0.31391334 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.87999459 |
2 | Asthma_Homo sapiens_hsa05310 | 3.82283389 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.61467502 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.25772309 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.22573587 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.86884582 |
7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.84030680 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.76858939 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63318395 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37116093 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33016798 |
12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.23068478 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12885503 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07016888 |
15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98807867 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90083006 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.86504995 |
18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.84511460 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78430946 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73263438 |
21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.66961795 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64943053 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52113123 |
24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47609421 |
25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47455753 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.46164257 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.42216070 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36232648 |
29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26522323 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24998306 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23605558 |
32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20425328 |
33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08041194 |
34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02953941 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96052105 |
36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91348993 |
37 | Measles_Homo sapiens_hsa05162 | 0.90270371 |
38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89708791 |
39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88214657 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85927169 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85624036 |
42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84939488 |
43 | Pertussis_Homo sapiens_hsa05133 | 0.84848841 |
44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84605131 |
45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82763218 |
46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82148232 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81426626 |
48 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80593666 |
49 | Legionellosis_Homo sapiens_hsa05134 | 0.80410826 |
50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77916372 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71340251 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.71103898 |
53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71021430 |
54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70460020 |
55 | Hepatitis B_Homo sapiens_hsa05161 | 0.69342039 |
56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68424772 |
57 | Phagosome_Homo sapiens_hsa04145 | 0.63672613 |
58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63304327 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61012716 |
60 | Bladder cancer_Homo sapiens_hsa05219 | 0.59796431 |
61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59430426 |
62 | Apoptosis_Homo sapiens_hsa04210 | 0.53877254 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53127555 |
64 | ABC transporters_Homo sapiens_hsa02010 | 0.52689513 |
65 | Malaria_Homo sapiens_hsa05144 | 0.52512210 |
66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51199516 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50805882 |
68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50471727 |
69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49332068 |
70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48841860 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47291569 |
72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47092174 |
73 | Phototransduction_Homo sapiens_hsa04744 | 0.44776648 |
74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41899236 |
75 | Morphine addiction_Homo sapiens_hsa05032 | 0.40997566 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40958120 |
77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40638809 |
78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40341374 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38945133 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35546779 |
81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34113921 |
82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33259185 |
83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33149816 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33021432 |
85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31247484 |
86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30858254 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29213273 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28386627 |
89 | Insulin resistance_Homo sapiens_hsa04931 | 0.26570285 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25925500 |
91 | Platelet activation_Homo sapiens_hsa04611 | 0.24430420 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.24285772 |
93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.22395829 |
94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20439079 |
95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19204684 |
96 | Salmonella infection_Homo sapiens_hsa05132 | 0.15173749 |
97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.13233914 |
98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.12951572 |
99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.12927457 |
100 | Long-term depression_Homo sapiens_hsa04730 | 0.12321791 |